RYAN REYNOLDS BRINGS ATTENTION TO A LESSER-KNOWN ASPECT OF PARKINSON’S

WATCH THE VIDEO
Click to play the "Ryan's Story" video
Click to play the "Ryan's Story" video Click to play the "Ryan's Story" video
En Español (Próximamente)
[PREVIEW HAS NO SOUND]

When my dad was diagnosed with Parkinson’s, I thought I knew what to expect with the physical symptoms, but no one warned us about the hallucinations and delusions which are often part of the disease. My dad was pretty stubborn but also strong. He didn't want to acknowledge he might be struggling to hold his grip on reality. I wish I knew then what I know now. I want this work to encourage conversations and destigmatize one of the toughest parts of Parkinson’s.”

—Ryan Reynolds, actor and advocate

Actor and advocate Ryan Reynolds shares his late father James’s silent struggle with Parkinson’s-related hallucinations and delusions, emphasizing early conversations and proper screening. Watch the videos your patients and their family members will be seeing to connect with them, answer their questions, and offer support.

HELP IDENTIFY PD PSYCHOSIS SYMPTOMS WITH A VALIDATED SCREENER

As part of routine appointments, have your patients or their caregivers complete the validated Self-Administered Screening Questionnaire for Parkinson’s Disease–Associated Psychosis (SASPAP). The SASPAP is a 4-question validated screening tool published in Movement Disorders.* Discuss the results and next steps to ensure these symptoms are identified before they progress.

En Español (Próximamente)

*©2023 International Parkinson and Movement Disorder Society (MDS). All rights reserved. Used with permission. This scale may not be copied, distributed or otherwise used in whole or in part without prior written consent of MDS.

50%

Over the course of their disease, about 50% of people with Parkinson’s disease (PD) may experience hallucinations and delusions.1

UP TO
90%

Despite the prevalence of hallucinations and delusions, up to 90% of patients and care partners do not proactively report these symptoms to their physicians.2,3

HALLUCINATIONS AND DELUSIONS CAN MANIFEST IN MULTIPLE WAYS

Hallucinations4-6

Vision
Auditory
Olfactory
Gustatory
Tactile

Delusions5-7

Jealousy
Persecutory
Reference

Hallucinations and delusions worsen the outlook for patients with PD:

  • Higher incidence of falls and fractures8
  • Increased hospital admissions and nursing home placements9,10
  • Increased mortality risk10,11

Caregivers of patients with PD psychosis experience greater burden 
and distress:

  • Higher incidence and increased severity of depression12,13
  • Increased risk for chronic illness14
  • Feelings of isolation12

HALLUCINATIONS AND DELUSIONS CAN HAVE A SIGNIFICANT IMPACT ON PATIENTS AND CAREGIVERS

References: 1. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010;67(8):996-1001. 2. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain. 2000;123(Pt 4):733-745. 3. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704-709. 4. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain. 2000;123(4):733-745. doi:10.1093/brain/123.4.733. 5. Voss T, Bahr D, Cummings J, Mills R, Ravina B, Williams H. Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson’s disease psychosis. Parkinsonism Relat Disord. 2013;19(3):295-299. doi:10.1016/j.parkreldis.2012.10.022. 6. Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson’s disease: report of an NINDS, NIMH work group. Mov Disord. 2007;22(8):1061-1068. doi:10.1002/mds.21382. 7. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa; 1984. 8. Forns J, Layton JB, Bartsch J, et al. Increased risk of falls and fractures in patients with psychosis and Parkinson disease. PLoS One. 2021;16(1):e0246121. doi:10.1371/journal.pone.0246121. 9. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc. 2000;48:938-942. 10. Wetmore JB, Li S, Yan H, et al. Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: retrospective cohort study. Parkinsonism Relat Disord. 2019;68:95-101. doi:10.1016/j.parkreldis.2019.10.018. 11. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology. 2010;75(14):1270-1276. 12. Mantri S, Klawson E, Albert S, et al. The experience of care partners of patients with Parkinson’s disease psychosis. PLoS One. 2021;16(3):e0248968. doi:10.1371/journal.pone.0248968. 13. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int J Geriatr Psychiatry. 1999;14(10):866-874. 14. Schrag A, Horvis A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35-41.